oveporexton

News

Takeda gets first OK for orexin narcolepsy drug, in China

China has become the first country to approve Takeda's first-in-class orexin agonist, oveporexton, for the sleep disorder narcolepsy.

News

Man yawning, covering his mouth with his hand

FDA kicks off review of Takeda's narcolepsy hopeful

The FDA has started a priority review of Takeda's oveporexton for sleep disorder narcolepsy, setting up a decision in the third quarter of the year.

News

Alkermes breaks new ground in narcolepsy with orexin drug

Alkermes' alixorexton is the first orexin 2 receptor agonist to show efficacy in phase 2 trials involving patients with both main narcolepsy subtypes.

News

Takeda's narcolepsy programme gets back on track

Takeda will move quickly ahead with regulatory filings for oveporexton as a treatment for narcolepsy after a pair of phase 3 wins.

Takeda gets first OK for orexin narcolepsy drug, in China

FDA kicks off review of Takeda's narcolepsy hopeful

Alkermes breaks new ground in narcolepsy with orexin drug

Takeda's narcolepsy programme gets back on track

Ex-BioNTech execs launch 'AI-native' cancer company

Discover a new era of healthcare panel engagement: Grounded ...

oveporexton

Editor's Picks